ELAB Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021
Period Ended	12/31/2023	12/31/2022	12/31/2021
Operating Revenue	$1.71 M	$766,277.00	$827.00
Cost of Revenue	$588,310.00	$324,002.00	$2,845.00
Gross Profit	$1.12 M	$442,275.00	-$2,018.00
Gross Profit Ratio	0.66	0.58	-2.44
Research and Development Expenses	$426,243.00	$228,747.00	$123,632.00
General & Administrative Expenses	$3.37 M	$1.54 M	$602,729.00
Selling & Marketing Expenses	$660,291.00	$192,863.00	$31,605.00
Selling, General & Administrative Expenses	$4.12 M	$1.80 M	$633,962.00
Other Expenses	-$339,150.00	-$198,440.00	-$25,450.00
Operating Expenses	$4.88 M	$2.23 M	$783,044.00
Cost And Expenses	$5.47 M	$2.55 M	$785,889.00
Interest Income	$5,564.00	$7,702.00	$0.00
Interest Expense	$19,525.00	$2,629.00	$0.00
Depreciation & Amortization	$11,649.00	$6,512.00	$2,757.00
EBITDA	-$3.75 M	-$1.78 M	-$782,300.00
EBITDA Ratio	-2.19	-2.33	-945.95
Operating Income	-$3.76 M	-$1.79 M	-$785,060.00
Operating Income Ratio	-2.2	-2.33	-949.29
Total Other Income/Expenses Net	-$541,437.00	-$11,978.00	$321.00
Income Before Tax	-$4.30 M	-$1.80 M	-$784,739.00
Income Before Tax Ratio	-2.51	-2.35	-948.9
Income Tax Expense	$1.00	-$2.00	$3.00
Net Income	-$4.30 M	-$1.80 M	-$784,739.00
Net Income Ratio	-2.51	-2.35	-948.9
EPS	-0.4	-0.19	-0.0453
EPS Diluted	-0.4	-0.19	-0.0453
Weighted Average Shares Out	$10.75 M	$9.53 M	$17.33 M
Weighted Average Shares Out Diluted	$10.75 M	$9.53 M	$17.33 M
Link

Elevai Labs, Inc. Common Stock (ELAB) Financials